植物性輔料市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、地區和競爭格局分類，2021-2031年

全球植物來源添加劑市場預計將從 2025 年的 24.1 億美元成長到 2031 年的 31.1 億美元，複合年成長率為 4.34%。

這些源自天然植物來源成分（如樹膠、纖維素和澱粉）的非活性物質，被用於營養補充劑和藥品的配方中，以改善加工性能、增強穩定性並輔助藥物傳輸。市場成長的主要驅動力是全球消費品和醫療保健產業對潔淨標示和天然成分的需求不斷成長，以及消費者對無過敏原、純素和素食產品的偏好轉變。有機貿易協會在2025年4月發布的報告也印證了這一趨勢，報告顯示，2024年美國經認證的有機產品銷售額成長了5.2%。這反映出消費者對天然產品的偏好日益增強，間接推動了對植物來源輔料的需求。

此外，促進在藥物研發中使用天然來源和永續成分的法規結構和措施正大力推動市場擴張。然而，市場成長的主要障礙在於新型植物來源添加劑複雜的監管核准流程。此流程通常需要全面的性能和毒性數據，以確保這些天然來源的替代品與傳統合成產品具有相當的安全性和有效性，導致產品上市時間延長。

市場促進因素

對環保且永續的醫藥原料日益成長的需求是全球植物來源輔料市場的主要驅動力。製藥公司越來越重視能夠體現其環境責任並滿足消費者對永續產品需求的原料，從而推動了對植物來源替代品的投資和創新。例如，黑田公司於2025年發布的《我們的目標》報告顯示，到2024年，56%的有機原料將來自生物基原料，凸顯了企業為滿足不斷變化的產業需求而對永續採購的堅定承諾。這種對生物基原料的投入正直接促進植物植物來源輔料在醫藥生產上的供應和應用。

此外，植物來源製劑的持續研發正在加速市場成長，拓展應用範圍並提升功能性。各公司正大力投資於新型植物來源輔料的研發和改進，以建構對患者友善且有效率的藥物遞送機制，力求確保其符合嚴格的藥品性能和品質標準。 Rocket公司於2026年3月發布的2025年全年財務報告充分體現了這一承諾，報告顯示，該公司2025年的總投資額達到2.63億歐元，這反映了其在拓展藥品解決方案和植物來源原料供應方面的大量資本投入。同樣，Kuroda公司於2026年2月發布的2025年財務報告顯示，剔除外匯波動的影響後，其藥品銷售額成長了4%。這主要得益於生物製藥和小分子藥物領域輔料銷售額的成長，凸顯了輔料在整個製藥產業日益成長的重要性。

市場挑戰

全球植物來源輔料市場擴張面臨的主要障礙之一是新型植物來源複雜的監管核准框架，該框架要求提供全面的性能和毒理學證據。嚴格的功效和安全性評估要求，以及與成熟合成添加劑同等的標準，迫使生產商投入大量時間和資源。因此，漫長的檢驗和開發階段構成了准入壁壘，阻礙了對新型植物來源物質的投資，並抑制了創新。

大量數據的產生以及後續的法規核准流程顯著延緩了新興植物來源輔料的推廣應用。 2025年5月，IPEC-Americas的回饋意見凸顯了這一延誤：與輔料改進相關的活動，例如測試、重組和監管核准，通常至少需要五年才能完成。如此漫長的週期對開發尖端植物來源的公司的投資回報率（ROI）產生了負面影響，降低了這些項目的經濟吸引力，並阻礙了其在膳食補充劑和製藥行業的廣泛應用。

市場趨勢

將3D列印和人工智慧（AI）技術應用於輔料設計，正在改變全球植物來源輔料市場。這些最尖端科技能夠精準且有效率地開發新型輔料，顯著推動個人化醫療和製劑改良。透過分析複雜的資料集，人工智慧演算法可以預測活性成分（API）與輔料的相容性，最佳化藥物遞送特性，並加速整個研發週期。這種技術協同作用極大地簡化了設計流程。正如Quotient Sciences在2025年12月出版的《製造化學家》（Manufacturing Chemist）雜誌中所指出的，在藥物研發中運用人工智慧技術可將製劑開發時間縮短30%至50%，從而顯著提高功能性植物來源輔料的商業化效率。

同時，植物來源輔料生產技術的顯著進步正成為一大趨勢，在維持這些特殊原料的可靠、高品質供應方面發揮著至關重要的作用。各公司正投資升級和擴大其生產基礎設施，以滿足對植物來源替代品日益成長的需求。這包括建立高效且永續的植物原料改質及萃取方法，以生產出均一性極佳、性能卓越的輔料。信越化學株式會社宣布計劃在2026年下半年前向其藥用纖維素業務投資100億日元，以此作為這一趨勢的象徵。此舉旨在透過建造一座新的植物來源（例如源自植物漿的藥用纖維素L-HPC）生產廠，以及擴大倉儲空間，來強化供應鏈。如此大規模的投資凸顯了該行業致力於改進和擴大用於各種營養補充劑和藥品的植物來源添加劑生產的堅定決心。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：植物性輔料的全球市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依類型（碳水化合物、蛋白質、聚合物、礦物質、糖苷/蠟、酯類、其他）
  • 依用途分類（粘合劑/稀釋劑、潤滑劑、崩壞、成膜劑/包衣劑、塑化劑、懸浮劑、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美植物性輔料市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲植物輔料市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區植物性輔料市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲植物性輔料市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲植物性輔料市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章 全球植物性輔料市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• DFE Pharma GmbH & Co. KG
• JRS Pharma GmbH & Co. KG
• Ashland Global Holdings Inc.
• BASF SE
• Evonik Industries AG
• Ingredion Incorporated
• Cargill, Incorporated
• FMC Corporation
• Lonza Group Ltd.
• DuPont de Nemours, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Plant Based Excipients Market is anticipated to expand from USD 2.41 Billion in 2025 to USD 3.11 Billion by 2031, representing a compound annual growth rate (CAGR) of 4.34%. Derived from natural botanical sources like gums, cellulose, and starch, these inactive substances are utilized in nutraceutical and pharmaceutical formulations to improve processing, boost stability, and aid drug delivery. The market's growth is primarily fueled by a rising worldwide demand for clean-label and natural ingredients in the consumer product and healthcare sectors, alongside a growing consumer shift toward allergen-free, vegan, and vegetarian options. Highlighting this shift, the Organic Trade Association reported in April 2025 that U.S. sales of certified organic goods grew by 5.2% in 2024, reflecting a widespread preference for natural products that indirectly boosts the need for plant-derived excipients.

Additionally, market expansion is heavily supported by regulatory frameworks and initiatives that promote the use of naturally derived and sustainable ingredients in drug development. Nevertheless, a major hurdle restricting market growth is the complicated regulatory approval procedure for new plant-based excipients. This process typically demands exhaustive performance and toxicological data to guarantee that these natural alternatives match the safety and effectiveness of conventional synthetic options, ultimately extending the time it takes to reach the market.

Market Driver

The increasing need for eco-friendly and sustainable pharmaceutical ingredients serves as a major catalyst for the global plant-based excipients market. Drug manufacturers are placing greater emphasis on raw materials that reflect environmental responsibility and cater to consumer desires for sustainable goods, prompting increased investment and innovation in plant-derived alternatives. Illustrating this trend, Croda's 'Our targets' report published in 2025 indicated that 56% of its organic raw material volume in 2024 came from bio-based sources, highlighting a strong dedication to sustainable procurement to satisfy shifting industry demands. Such dedication to bio-based inputs directly bolsters the accessibility and utilization of plant-derived excipients within pharmaceutical production.

Moreover, market growth is accelerated by ongoing research and development breakthroughs in plant-based formulations, which broaden application scopes and improve functional attributes. Businesses are investing heavily to identify and refine new plant-derived excipients, making certain they comply with rigorous pharmaceutical performance and quality benchmarks to create patient-friendly, highly effective drug delivery mechanisms. Demonstrating this commitment, Roquette's Full-Year Results Announcement from March 2026 showed total investments reaching €263 million in 2025, reflecting massive capital funneled into expanding its pharmaceutical solutions and plant-based ingredient offerings. Similarly, Croda's 2025 financial results, released in February 2026, reported a 4% growth in constant currency for its pharma sales, largely propelled by increased excipient sales across biologic and small molecule applications, emphasizing the growing importance of excipients in the wider pharmaceutical landscape.

Market Challenge

A major obstacle hindering the expansion of the Global Plant Based Excipients Market is the intricate regulatory approval framework for new plant-derived excipients, which requires exhaustive performance and toxicological evidence. The strict mandate for thorough efficacy and safety evaluations-mirroring the standards set for proven synthetic counterparts-forces manufacturers to commit substantial financial and temporal resources. Consequently, the lengthy validation and development stages establish steep barriers to entry, which can deter investment and stifle innovation in novel plant-based substances.

Generating this extensive data and navigating the ensuing regulatory assessments significantly postpone the market introduction of emerging plant-based excipients. Highlighting this delay, feedback provided by IPEC-Americas in May 2025 indicated that activities related to excipient modifications, such as testing, reformulation, and securing regulatory clearance, typically take at least five years to complete. Such prolonged schedules negatively affect the potential return on investment for enterprises creating cutting-edge plant-based excipients, rendering these projects less financially appealing and hindering their broad integration throughout the nutraceutical and pharmaceutical industries.

Market Trends

The integration of 3D printing and Artificial Intelligence (AI) in excipient design is currently transforming the global plant-based excipients market. These cutting-edge technologies facilitate the accurate and streamlined creation of new excipients, heavily impacting personalized medicine and formulation enhancement. By analyzing intricate datasets, AI algorithms can foresee API-excipient compatibility and perfect drug delivery characteristics, hastening the overall research and development cycle. This technological synergy drastically simplifies design workflows; as noted by Quotient Sciences in a December 2025 Manufacturing Chemist publication, leveraging AI in drug development can slash formulation timelines by 30-50%, providing essential efficiency leaps to rapidly commercialize functional plant-based excipients.

Concurrently, breakthroughs in manufacturing technologies for plant-derived excipients represent another major trend, playing a vital role in maintaining a reliable, premium supply of these niche ingredients. Organizations are channeling funds into upgrading and broadening their production infrastructure to satisfy the surging need for plant-based substitutes. This entails establishing highly efficient and sustainable methods for modifying and extracting botanical materials to yield excipients with unmatched consistency and performance. Illustrating this movement, Shin-Etsu Chemical declared intentions to inject 10 billion yen into its pharmaceutical cellulose operations by the second half of 2026, aiming to construct fresh manufacturing plants and double its storage space for plant-derived excipients such as L-HPC, a pharmaceutical cellulose derived from plant pulp, to fortify its supply chain. These substantial investments highlight the sector's dedication to improving and expanding plant-based excipient production for various nutraceutical and pharmaceutical uses.

Key Market Players

• DFE Pharma GmbH & Co. KG
• JRS Pharma GmbH & Co. KG
• Ashland Global Holdings Inc.
• BASF SE
• Evonik Industries AG
• Ingredion Incorporated
• Cargill, Incorporated
• FMC Corporation
• Lonza Group Ltd.
• DuPont de Nemours, Inc.

Report Scope

In this report, the Global Plant Based Excipients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Plant Based Excipients Market, By Type

• Carbohydrates
• Proteins
• Polymers
• Minerals
• Glycoside & Waxes
• Esters
• Others

Plant Based Excipients Market, By Application

• Binders & Diluents
• Glidants
• Lubricants & Disintegrants
• Film Forming & Coating Agents
• Plasticizers
• Suspending Agents
• Others

Plant Based Excipients Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Plant Based Excipients Market.

Available Customizations:

Global Plant Based Excipients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Plant Based Excipients Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Carbohydrates, Proteins, Polymers, Minerals, Glycoside & Waxes, Esters, Others)
  • 5.2.2. By Application (Binders & Diluents, Glidants, Lubricants & Disintegrants, Film Forming & Coating Agents, Plasticizers, Suspending Agents, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Plant Based Excipients Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Plant Based Excipients Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Plant Based Excipients Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Plant Based Excipients Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Plant Based Excipients Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Plant Based Excipients Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. France Plant Based Excipients Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Plant Based Excipients Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Plant Based Excipients Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Plant Based Excipients Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia Pacific Plant Based Excipients Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Plant Based Excipients Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Plant Based Excipients Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Plant Based Excipients Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Plant Based Excipients Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Plant Based Excipients Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. Middle East & Africa Plant Based Excipients Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Plant Based Excipients Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Plant Based Excipients Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Plant Based Excipients Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. South America Plant Based Excipients Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Plant Based Excipients Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Plant Based Excipients Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Plant Based Excipients Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Plant Based Excipients Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. DFE Pharma GmbH & Co. KG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. JRS Pharma GmbH & Co. KG
• 15.3. Ashland Global Holdings Inc.
• 15.4. BASF SE
• 15.5. Evonik Industries AG
• 15.6. Ingredion Incorporated
• 15.7. Cargill, Incorporated
• 15.8. FMC Corporation
• 15.9. Lonza Group Ltd.
• 15.10. DuPont de Nemours, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer